Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Saudi Pharmaceutical Journal is Scopus-indexed (Q1, CiteScore 8.2), WoS SCIE, DOAJ. Published by Springer International Publishing.
Checked against the index lists dated .
ISSN 1319-0164Verify ISSN ↗2213-7475Verify ISSN ↗
Publisher: Springer International Publishing
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology | 61 / 328 | 81st | Q1 |
| Pharmaceutical Science | 38 / 191 | 80th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1996–present, best quartile Q1, CiteScore 8.2.
Saudi Pharmaceutical Journal is Q1 in Pharmacology (rank 61 of 328) and Q1 in Pharmaceutical Science (rank 38 of 191), by CiteScore 2025.
Saudi Pharmaceutical Journal is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 8.2, which places it in quartile Q1 at the 81st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.762, quartile Q2, with an H-index of 91.
The publisher lists an article processing charge of about US$2,690 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Saudi Pharmaceutical Journal is published by Springer International Publishing. Its print ISSN is 1319-0164 and its online ISSN is 2213-7475.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Saudi Pharmaceutical Journal has an h-index of 105 and a 2-year mean of 6.15 citations per paper (OpenAlex). Its Scopus CiteScore is 8.2, quartile Q1. On 2-year citations it ranks #36 of 319 Scopus journals in Pharmacology.
Saudi Pharmaceutical Journal published 54 papers in 2025; its busiest recent year was 2023 with 347. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from Saudi Arabia (53.7%), China (15.3%) and Egypt (7.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 16 retracted papers are recorded (6.9 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.